This would be a unique feature that, if confirmed through phase III trials, may have a significant impact on the clinical management of PD
Francesco Puppi, recent podium finisher of the Western States 100, wrote a thoughtful piece about the state of drug testing in ultras following the high profile test failure of Joyline Chepngeno in 2025
Body composition tracking via DEXA or other methods quantifies muscle gain and fat loss
This article provides a comprehensive literature review of the historical, histologic, and clinical aspects of dysplastic nevi
Exceptions were a 19 % and a 22 % reduction in warfarin C max when administered with lixisenatide or dulaglutide (both doses of 1.5 mg and 4.5 mg), respectively [15, 31, 32] that were not considered to be of clinical importance